Author:
Sakurai Yoichi,Karaki Hirokazu,Nakamura Yusuke,Fukuda Hiroyuki,Okaya Tomohisa,Oheda Yoshio,Yokoyama Yuya,Hirai Futoshi,Abe Michikazu,Sugano Isamu
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Hauso O, Gustafsson BI, Kidd M, et al. Neuroendocrine tumor epidemiology: contrasting Norway and North America. Cancer. 2008;113:2655–64.
2. Yao JC, Hassan M, Phan A, et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26:3063–72.
3. Obernforfer S. Karzinoide tumoren desn dunndarms. Frankfurt Z Path. 1907;1:426–32.
4. Capella C, Heitz PU, Höfler H, Solcia E, Klöppel G. Revised classification of neuroendocrine tumours of the lung, pancreas and gut. Virchows Arch. 1995;425:547–60.
5. Japanese Neuroendocrine Tumors Society (JNETS). Clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms (GEP-NEN). Kanehara Inc.; 2019. p. 103–4.